G80.0 Q66.0
Conditions
Interventions
Group 1: Time 1: gait analysis before injection
Time 2: gait analysis 6 weeks after injection
Time 3: gait analysis 18 weeks after injection
Sponsors
Universitätsklinik HeidelbergKlinik für Orthopädie und Unfallchirurgie
Eligibility
Sex/Gender
All
Age
5 Years to 17 Years
Inclusion criteria
Inclusion criteria: The diagnosis: Spastic cerebral palsy (GMFCS Level I-II) and simultaneously present Genu Rekurvatum (knee joint extension = 5° in the 3-D gait analysis) with dynamic pointed foot (dorsal extension in the clinical examination =0°, tip-toe gait in the 3-D gait analysis). Standardized clinical examination and instrumental 3D gait analysis directly before Botox treatment and 6 weeks after botulinum toxin A injection.
Exclusion criteria
Exclusion criteria: Pre-operative treatment of the lower extremity Refusal to use the data already collected and wish to discontinue studies by the patient or the parents/legal representatives Botulinum toxin A injection within the last 6 months Walking aids (GMFCS III) Severe mental disability Non Compliance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| After injection of botulinum toxin A into the calf muscles, significant differences in ankle joint mobility with an altered range of motion of the dorsal extension or a reduction of the toe in the stance phase (parameters of the 3D gait analysis). | — |
Secondary
| Measure | Time frame |
|---|---|
| Observational study It will also be investigated whether injection locations/heights have an influence on function. | — |
Countries
Germany
Outcome results
None listed